Our blog
logo

An option to modify the course of Parkinson’s progression

21 de November de 2023

Evaluation of an inhibitor of the LRRK 2 gene in Parkinson’s patients. Oral tract. We…

Compartir:
Posted in: Parkinson
logo

An option for patients with Parkinson’s and LRRK2 mutation

21 de November de 2023

Trial on LRRK2 mutation in Parkinson’s is about to be completed. Our Trials Unit is…

Compartir:
Posted in: Parkinson
logo

An option for patients with Parkinson’s and LRRK2 mutation

21 de November de 2023

Trial on LRRK2 mutation in Parkinson’s disease is about to be completed. Our Clinical Trials…

Compartir:
Posted in: Uncategorised
logo

Positive result from the Pivotal trial with levodopa administered by continuous subcutaneous infusion

8 de May de 2023

Highly positive results from the pivotal Phase III BouNDless trial evaluating ND0612 in patients with…

Compartir:
Posted in: Parkinson
logo

New inhaled levodopa INBRIJA authorised in Spain

8 de May de 2023

The new formulation of inhaled levodopa, Inbrija, has been approved for marketing in Spain. Manufactured…

Compartir:
Posted in: Parkinson
Area privada5

new drug for early-stage Alzheimer’s disease

16 de January de 2023

On Epiphany, the U.S. Food and Drug Administration approved a new drug for early-stage Alzheimer’s…

Compartir:
Area privada1

We tested a drug to treat agitation in Alzheimer’s patients

3 de June de 2021

The General University Hospital of Catalonia is the first recognized center in Europe to evaluate…

Compartir:
Posted in: Alzeimer, Uncategorised
Blogudic1

The General University Hospital of Catalonia (HUGC), through the Clinical Research Unit (UDIC), has included the world’s first patient in a phase I clinical trial on Alzheimer’s.

3 de June de 2021

This study could improve the efficacy and safety of the products being evaluated to try…

Compartir:
Posted in: Alzeimer, Uncategorised
logo

FDA approves sublingual apomorphine in off periods

22 de July de 2020

The FDA has approved the use of sublingual apomorphine (KYNMOBI) in motor blocks, in Parkinson’s…

Compartir:
Posted in: Parkinson, Uncategorised
nota legal

US authorizes an intranasal levodopa.

8 de April de 2020

An intranasal levodopa has been authorized in the US to treat off blockages, called Inbrija….

Compartir:
Posted in: Parkinson
Proyectos1

Levodopa infusion pump

2 de April de 2020

Levodopa infusion pump We evaluate an ultraconcentrated levodopa administered subcutaneously in patients with motor fluctuations….

Compartir:
Posted in: Parkinson
Area privada1

Activation of phase I trial in Progressive Supranuclear Palsy

11 de March de 2020

Our Unit has achieved to be activated in this outstanding project and so serious pathology….

Compartir:
Posted in: Parkinson
Page 1 of 41 2 3 4

Compartir: